Tissue-Engineering the Intestine: The Trials before the Trials

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Tissue Engineering

Background:

• Short bowel syndrome (SBS) necessitates advanced treatments.
• Current therapeutic options for SBS have limitations.
• Tissue engineering offers a promising avenue for intestinal regeneration.

Purpose of the Study:

• To discuss experimental considerations for developing a tissue-engineered intestine.
• To address challenges in creating functional intestinal tissue.
• To outline strategies for treating short bowel syndrome using engineered tissues.

Main Methods:

• Interdisciplinary collaboration within the INTENS Consortium.
• Evaluation of cell sources for intestinal tissue engineering.
• Assessment of scaffold materials and design strategies.
• Consideration of assembly and functionalization techniques.

Main Results:

• Identification of critical experimental factors for intestinal tissue engineering.
• Discussion of challenges in cell sourcing and scaffold selection.
• Exploration of design strategies for achieving functional tissue assembly.
• Highlighting the need for innovative engineering solutions.

Conclusions:

• Successful generation of a tissue-engineered intestine requires careful consideration of multiple experimental parameters.
• Addressing challenges in cell source, scaffold choice, and design is crucial for therapeutic success.
• The INTENS Consortium's insights provide a roadmap for advancing intestinal tissue engineering for SBS treatment.